Education
About Us
Working with TipRanks
Follow Us
Pharma Bio Services (PBSV)
OTHER OTC:PBSV
PBSV Stock Chart & Stats
$0.54
-$0.14(-25.27%)
At close: 4:00 PM EST
$0.54
-$0.14(-25.27%)
Day’s Range― - ―
52-Week Range$0.35 - $1.36
Previous CloseN/A
Volume2.02K
Average Volume (3M)2.53K
Market Cap
$12.32M
Enterprise Value$3.34M
Total Cash (Recent Filing)$10.73B
Total Debt (Recent Filing)$71.36M
Price to Earnings (P/E)―
Beta-0.23
Next Earnings
Feb 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding22,918,093
10 Day Avg. Volume1,930
30 Day Avg. Volume2,531
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)0.97
Price to Sales (P/S)1.40
P/FCF Ratio-18.34
Enterprise Value/Market Cap0.27
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda-9.90
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Pharma Bio Services News
PBSV FAQ
What was Pharma Bio Services’s price range in the past 12 months?
Pharma Bio Services lowest stock price was $0.34 and its highest was $1.36 in the past 12 months.
What is Pharma Bio Services’s market cap?
Pharma Bio Services’s market cap is $12.32M.
When is Pharma Bio Services’s upcoming earnings report date?
Pharma Bio Services’s upcoming earnings report date is Feb 04, 2026 which is in 20 days.
How were Pharma Bio Services’s earnings last quarter?
Pharma Bio Services released its earnings results on Sep 10, 2025. The company reported -$0.01 earnings per share for the quarter, the consensus estimate of -$0.01 by $0.
Is Pharma Bio Services overvalued?
According to Wall Street analysts Pharma Bio Services’s price is currently Overvalued.
Does Pharma Bio Services pay dividends?
Pharma Bio Services pays a Notavailable dividend of $0.075 which represents an annual dividend yield of N/A. See more information on Pharma Bio Services dividends here
What is Pharma Bio Services’s EPS estimate?
Pharma Bio Services’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharma Bio Services have?
Pharma Bio Services has 22,918,093 shares outstanding.
What happened to Pharma Bio Services’s price movement after its last earnings report?
Pharma Bio Services reported an EPS of -$0.01 in its last earnings report, expectations of -$0.01. Following the earnings report the stock price went down -2.742%.
Which hedge fund is a major shareholder of Pharma Bio Services?
Currently, no hedge funds are holding shares in PBSV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Pharma Bio Services
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil. Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Technical Analysis
Zhongchao
―
Healthcare Triangle
―
VSee Health
―
Aclarion, Inc.
―
BullFrog AI Holdings, Inc.
―
Ownership Overview
10.79%
Insiders
― Other Institutional Investors
89.21% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---